Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 63,659 | 73,939 | 60,035 | 55,887 | 332,795 |
| Depreciation Amortization | 22,055 | 12,097 | 4,032 | 2,470 | 13,003 |
| Income taxes - deferred | -11,463 | -6,013 | -7,485 | -8,215 | 17,251 |
| Accounts receivable | -40,120 | -31,792 | -2,881 | N/A | 300 |
| Accounts payable and accrued liabilities | 6,621 | 6,740 | 679 | 268 | 76 |
| Other Working Capital | -13,892 | -10,556 | 8,748 | 14,283 | 9,191 |
| Other Operating Activity | 74,858 | 41,650 | 31,624 | 27,813 | -71,151 |
| Operating Cash Flow | $101,718 | $86,065 | $94,752 | $92,506 | $301,465 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -84,010 | -75,000 | -75,000 | N/A | N/A |
| PPE Investments | -25 | N/A | N/A | N/A | -9 |
| Net Acquisitions | -109,938 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -22,952 | -7,985 | N/A | N/A | N/A |
| Sale Of Investment | 4,680 | 1,680 | 1,681 | 273 | 1,947 |
| Purchase Sale Intangibles | 13,082 | -12,260 | 31,909 | 17,221 | -71,593 |
| Other Investing Activity | 67,735 | -75,545 | -83,029 | 12,221 | -81,586 |
| Investing Cash Flow | $-144,510 | $-156,850 | $-156,348 | $12,494 | $-79,648 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 100,000 |
| Debt Issued | 150,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -120,000 | N/A | N/A | N/A | -220,397 |
| Dividend Paid | -16,583 | -16,433 | -16,433 | -8,233 | -98,307 |
| Other Financing Activity | -42,354 | -25,075 | -25,000 | -25,000 | -75,607 |
| Financing Cash Flow | $-28,937 | $-41,508 | $-41,433 | $-33,233 | $-294,311 |
| Beginning Cash Position | 218,883 | 218,883 | 218,883 | 218,883 | 291,377 |
| End Cash Position | 147,154 | 106,590 | 115,854 | 290,650 | 218,883 |
| Net Cash Flow | $-71,729 | $-112,293 | $-103,029 | $71,767 | $-72,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 101,718 | 86,065 | 94,752 | 92,506 | 301,465 |
| Capital Expenditure | -25 | N/A | N/A | N/A | -9 |
| Free Cash Flow | 101,693 | 86,065 | 94,752 | 92,506 | 301,456 |